Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA expression profile from retinoblastoma tumors and pediatric controls

ABSTRACT: MicroRNA expression profile from retinoblastoma tumors and pediatric controls

PROVIDER: PRJNA860599 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

mRNA expression profile from retinoblastoma tumors and pediatric controls

Project description:mRNA expression profile from retinoblastoma tumors and pediatric controls

| PRJNA859173 | ENA

MicroRNA expression profile from retinoblastoma tumors and pediatric controls

Project description:To discover differentially expressed microRNA's in Rb tumors compared to pediatric retina

2022-07-21 | GSE208677 | GEO

mRNA expression profile from retinoblastoma tumors and pediatric controls

Project description:To discover differentially expressed mRNA's in Rb tumors compared to pediatric retina

2022-07-18 | GSE208143 | GEO

microRNA expression profile of pediatric adrenocortical tumors

Project description:microRNA expression profile of pediatric adrenocortical tumors

| PRJNA715778 | ENA

Retinoblastoma tumors NGS data

Project description:Retinoblastoma tumors NGS data

| PRJEB6630 | ENA

Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors

Project description:Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors

| PRJNA517916 | ENA

QUANTITATIVE PHOSPHOPROTEOMIC PROFILING OF PRIMARY RETINOBLASTOMA TUMORS

Project description:Retinoblastoma is a malignant tumor of the retina which most often occurs in children below 5 years of age with an incident rate of about 1 in 15,000 to 18,000 live births. Retinoblastoma is the first ever cancer that was reported to have a genetic basis. It occurs widely due to inactivating mutations in RB1 gene. Gene expression studies, copy number variation analysis, epigenetic profiling including miRNA and methylation of retinoblastoma has been carried to understand the disease mechanism and key players in the disease. Our group has earlier performed differential proteomics of retinoblastoma to identify proteins of therapeutic importance. However, there are no studies to understand the signalling mechanisms associated with retinoblastoma. Hence, global phosphoproteomics of retinoblastoma was carried out to identify signalling events associated with this cancer. Our study identified stress response proteins to be hyper phosphorylated which included H2AFX and sirtuin 1. In particular, Ser140 of H2AFX also known as gamma-H2AX was found to be hyperphosphorylated in retinoblastoma that indicated activation of DNA damage response pathways. We also observed activation of anti-apoptotic proteins in retinoblastoma compared to control. These observations showed activation of survival pathways and signalling networks activated in tumors.

2019-11-11 | PXD007228 | Pride

Expression of PRAME in retinoblastoma primary tumors

Project description:Transcriptome analysis of partially degraded and fragmented RNA samples from retinoblastoma primary tumors. Global gene expression profiling has shown great promise in high-throughput biomarker discovery for early disease detection in Retinoblastoma tumors. In this analysis we have used 3 retinoblastoma primary tumors in triplicates which was normalised against human healthy Retina. Here, we have used nanogram scale of retinoblastoma RNA, processed in HUMAN GENE 1.0 ST ARRAYS.

2010-10-14 | GSE24673 | GEO

Expression of PRAME in retinoblastoma primary tumors

2010-10-14 | E-GEOD-24673 | biostudies-arrayexpress

microRNA expression profile of pediatric adrenocortical tumors

Project description:Here, we used a microarray technique to provide miRNA expression data of a set of 37 adrenocortical tumors (ACT) and 9 non-neoplastic adrenal controls from Brazilian patients assisted in two treatment centers in the state of São Paulo (HC-FMRP-USP and Centro Infantil Boldrini of Campinas).

2022-01-12 | GSE169253 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data